Kinnari Patel - 12 Aug 2022 Form 4 Insider Report for ROCKET PHARMACEUTICALS, INC. (RCKT)

Role
President & Chief Operating Officer
Signature
/s/ Martin Wilson, as attorney-in-fact for Kinnari Patel
Issuer symbol
RCKT
Transactions as of
12 Aug 2022
Transactions value $
$0
Form type
4
Filing time
16 Aug 2022, 17:31:09 UTC
Previous filing
16 Feb 2022
Next filing
22 Feb 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RCKT Restricted Stock Units Award $0 +52.5K $0.00 52.5K 12 Aug 2022 Common Stock 52.5K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
F2 The restricted stock units will become fully vested on August 12, 2025.

Remarks:

President & Chief Operating Officer